Pilot Study Using an Online Patient-Reported Outcome Measures Portal to Optimize Breast Cancer Follow-up Care
Most breast cancer cells (70-75%) have estrogen and/or progesterone receptors, and can be treated with 5-10 years of anti-hormonal therapy to prevent breast cancer from growing. However, many breast cancer patients (40-50%) do not take their recommended daily anti-hormonal therapy, which could potentially increase their risk of dying by 49%. Main reasons women do not take anti-hormonal medications are unpleasant side effects and lack of access to effective follow-up care. To better support women, the After Breast Cancer (ABC) clinic was created by BC Cancer and BC Women’s Hospital.